Renalytix Share Discussion Threads

[74tom] 18/8/2021 15:28

I've bought a decent chunk on NASDAQ, it's rare to get such a move on no news. You can get the live trades on ADVFN with the US package, but not the historics. It looks as if we were hit with a sell of around 80k shares at the open, with daily average volume of just 40k ish shares over the last month, it's hit the price for six. Interesting to see what happens next...

[wan] 18/8/2021 15:24

I recall that Kidneyintelx utilizes a diverse range of data inputs, including genetics.

Time will tell if this will prove to represent an opportunity ahead of a potentially transformation year, but I decided to increase my exposure.

[pugugly] 18/8/2021 15:19

wtf_ down 21% on apparently no actionable news-

[elsa7878] 18/8/2021 15:08

Interesting - thanks.

[serratia] 18/8/2021 15:07

Might be useful -

[homebrewruss] 18/8/2021 14:58

Is there an easy way to see the latest trades in the US?

[mysteronz] 18/8/2021 14:41

One of the downsides of US dual listing, fk all news and its down 20% on meagre volume.

Tail wagging the dog

[donald pond] 18/8/2021 14:36

Taking a reaming in US, anyone know why?

[toffeeman] 13/8/2021 19:40

He knows what he is doing - very reassuring presentation.

[mr roper] 13/8/2021 14:07

Yup. Excellent listen. Next 6 mths could be transformational

[wan] 13/8/2021 07:32

Worth listening to, a very interesting and encouraging interview with the CEO is now available -

Renalytix AI plc
August 11, 2021 2:30 p.m. ET
Canaccord Genuity 41st Annual Growth Conference

htTTps://investors.renalytixai.com/events/event-details/41st-annual-canaccord-genuity-virtual-global-growth-conference

[wan] 10/8/2021 07:50

Reminder -

Renalytix’s management is scheduled to present at the Canaccord Genuity Global Growth Conference on Wednesday, August 11 at 2:30pm EDT. Interested parties may access a live and archived webcast of the presentations on the “InvestorsR21; section of the company website at investors.renalytix.com.

[wan] 09/8/2021 08:00

Relevant post from the EKF thread -

The following is not going to set the share price on fire, but as indicated by Bio-techne, it will likely provide for 'another' sustainable long term source of revenue -

Bio-Techne Corporation (TECH) Q4 2021 Earnings Call Transcript
TECH earnings call for the period ending June 30, 2021.
Aug 5, 2021 at 4:01PM

COVID was an estimated 3% tailwind to our business in Q4 and approximately 4% tailwind for the year, including revenue from sales of the Kantaro IgG antibody serology kit. Encouragingly, there is growing interest in niche markets forming around our COVID serology assay offering, specifically as a tool to identify immunocompromised individuals that may not have the antibody response following vaccination to neutralize the virus.

We expect the COVID research and diagnostics will be around for many years, particularly as new viral strains continue to emerge, making this tailwind a sustainable new layer of our product portfolio going forward.
Excerpt available at Fool.com -

[wan] 03/8/2021 10:09

To repeat from my previous post 1192, James McCullough, CEO stated during a conference call back in June, that previously he would not allow fixed overheads to build e.g. key hires to drive its commercialization strategy in the United States......until you have either direct line of sight on payments or you have already secured payment.

In this regard, I note that efforts to grow and expand the team continues, which is a ramp up that we were guided to expect -

14 Renalytix Jobs in Worldwide

[mr roper] 29/7/2021 21:27

Wouldn’t worry too much. It’s been flying lately. Just taking a breather before the next leg and the new highs.

Would be thinking fda approval should come in the next month or so.

[goldeast] 29/7/2021 20:09

The same thing happened the day before Kantaro received FDA approval.

[toffeeman] 29/7/2021 19:38

Down 10% in the US - any ideas?

[donald pond] 28/7/2021 22:16

All looking rosy suddenly. Bon chance, mes freres

[mr roper] 28/7/2021 21:20

$rnlx +7% tonight. Fda incoming?

[sspurt] 28/7/2021 16:37

1150p close - market bidding for stock.
Nice.

[bertiebingo] 28/7/2021 08:23

Appointment is re Audit and nomination committee, nothing exciting but help the corporate strength in time regarding future operational appointments.

[wan] 28/7/2021 07:41

And to quote the Chairman -

“We are delighted to have a professional of Ann’s capabilities on board as Renalytix enters into a substantial growth phase,”

[mr roper] 28/7/2021 07:36

Another high calibre appointment today. Onwards and upwards

[wan] 28/7/2021 06:13

I missed this -

NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the company will be presenting at the upcoming 41st Annual Canaccord Genuity Virtual Global Growth Conference.

Renalytix’s management is scheduled to present at the Canaccord Genuity Global Growth Conference on Wednesday, August 11 at 2:30pm EDT. Interested parties may access a live and archived webcast of the presentations on the “Investors” section of the company website at investors.renalytix.com.